Mortality trends in idiopathic pulmonary fibrosis in Europe between 2013 and 2018.

Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE

Publication: Sheffield, United Kingdom : European Respiratory Society
Original Publication: Copenhagen : Published jointly by the Society and Munksgaard, 1988-

Idiopathic Pulmonary Fibrosis*/mortality ; Idiopathic Pulmonary Fibrosis*/epidemiology; Humans ; Male ; Female ; Europe/epidemiology ; Aged ; Middle Aged ; Aged, 80 and over ; Mortality/trends ; Sex Distribution ; Age Distribution ; Adult ; Databases, Factual ; European Union/statistics & numerical data

Background: Previous research has suggested that the incidence of idiopathic pulmonary fibrosis (IPF) is increasing in the UK and elsewhere. The aim of this study is to provide contemporary estimates of IPF mortality rates across 24 European Union (EU) countries from 2013 to 2018, using death certificate data from the European Statistics Institution (EUROSTAT) database.
Methods: We extracted country data for IPF (International Classification of Diseases, 10th Revision: code J84.1) mortality from the EUROSTAT dataset. We calculated country-, age- and sex-specific death registration rates between 2013 and 2018. We used direct standardisation to compare rates between countries. We calculated annual trends in mortality rate ratios using a segmented regression model.
Results: The overall standardised mortality rate in 24 EU countries during this period was 3.90 (95% CI 3.80-3.90) per 100 000 person-years, with the rate rising from 3.70 in 2013 to 4.00 in 2018 (average annual percent change 1.74%, 95% CI 0.91-2.59%). We observed substantial inter-country differences, with the highest rates detected in Ireland, the UK and Finland, the lowest rate in Bulgaria, and middle rates in Germany, Greece, Italy, the Netherlands, Portugal and Slovenia.
Conclusions: The IPF mortality rate is increasing across Europe. There are currently more than 17 000 deaths recorded from IPF each year in Europe but the marked geographical differences we observed suggest that this figure may underestimate the true rate considerably.
Competing Interests: Conflict of interest: The authors have no potential conflicts of interest to disclose.
(Copyright ©The authors 2024.)

Comment in: Eur Respir J. 2024 Aug 22;64(2):2401305. doi: 10.1183/13993003.01305-2024. (PMID: 39174288)

J Forensic Leg Med. 2020 Oct;75:102052. (PMID: 32891932)
Eur Respir J. 2018 Jan 18;51(1):. (PMID: 29348182)
BMC Pulm Med. 2023 Jul 11;23(1):256. (PMID: 37434192)
N Engl J Med. 2014 May 29;370(22):2083-92. (PMID: 24836312)
ERJ Open Res. 2022 Jul 11;8(3):. (PMID: 35821757)
PLoS Med. 2015 Oct 06;12(10):e1001885. (PMID: 26440803)
Am J Respir Crit Care Med. 2007 Aug 1;176(3):277-84. (PMID: 17478620)
Am J Respir Crit Care Med. 2019 Oct 1;200(7):929-931. (PMID: 31225965)
Adv Ther. 2018 May;35(5):724-736. (PMID: 29644539)
N Engl J Med. 2014 May 29;370(22):2071-82. (PMID: 24836310)
BMJ. 1990 Nov 3;301(6759):1017-21. (PMID: 2249048)
Lancet. 2021 Jun 19;397(10292):2337-2360. (PMID: 34051883)
ERJ Open Res. 2019 Oct 21;5(4):. (PMID: 31649949)
Am J Respir Crit Care Med. 2019 Jul 15;200(2):256-258. (PMID: 30973756)
Chest. 2013 Apr;143(4):1078-1084. (PMID: 23188187)
Eur Respir J. 2015 Sep;46(3):795-806. (PMID: 25976683)
Chest. 2021 Nov;160(5):1751-1763. (PMID: 34217681)
Thorax. 2011 Jun;66(6):462-7. (PMID: 21525528)

Date Created: 20240613 Date Completed: 20240822 Latest Revision: 20240824

20240826

PMC11339406

10.1183/13993003.02080-2023

38871377